Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.36 |
| ▸ | RAPGEF4 | Q8WZA2 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28399885 | 0.77 | HTR7 (0.45) | ALDH1A1MAPTHTTSMN1; SMN2KMT2A | |
| SCHEMBL34512 | 0.75 | ALDH1A1 (0.35) | ALDH1A1MAPTNPSR1POLBHTT | |
| SCHEMBL20106885 | 0.74 | ALDH1A1 (0.60) | ALDH1A1MAPTNPSR1POLBHTT | |
| Hydrochloric Acid SCHEMBL552835 | 0.73 | ALDH1A1 (0.34) | ALDH1A1MAPTNPSR1POLBHTT | |
| Bromide SCHEMBL30353850 | 0.73 | ALDH1A1 (0.34) | ALDH1A1MAPTNPSR1POLBHTT | |
| Iodide SCHEMBL28719252 | 0.73 | ALDH1A1 (0.34) | ALDH1A1MAPTNPSR1POLBHTT | |
| SCHEMBL12867936 | 0.73 | ALDH1A1 (0.39) | ALDH1A1MAPTNPSR1POLBHTT | |
| SCHEMBL7945380 | 0.72 | ALDH1A1 (0.34) | ALDH1A1MAPTNPSR1POLBHTT | |
| SCHEMBL22188949 | 0.72 | ALDH1A1 (0.34) | ALDH1A1MAPTNPSR1POLBHTT | |
| SCHEMBL2895440 | 0.72 | ALDH1A1 (0.34) | ALDH1A1MAPTNPSR1POLBHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107434838-B | Phosphorus-containing olefin polymer, preparation method thereof, composition thereof and finished product | 台光电子材料股份有限公司 | 2020-09-18 | — | — | CN | disclosed |
| CN-103936793-B | Catalyst containing carbene ligand, its preparation method and its application in double decomposition reaction | 光明创新（武汉）有限公司 | 2017-02-08 | — | — | CN | disclosed |
| CN-106103472-A | Stabilized polypeptides and uses thereof | 哈佛大学的校长及成员们 | 2016-11-09 | — | — | CN | disclosed |
| US-9334297-B2 | Chiral imidazolium salts for asymmetric catalysis | NORTHWESTERN UNIVERSITY (US) | 2016-05-10 | — | — | US | disclosed |
| US-20160075728-A1 | Chiral Imidazolium Salts for Asymmetric Catalysis | NATIONAL SCIENCE FOUNDATION | 2016-03-17 | — | — | US | disclosed |
| EP-1615949-A1 | PROCESS FOR THE PREPARATION OF MACROCYCLIC COMPOUNDS BY RUTHENIUM COMPLEX CATALYSED METATHESIS REACTION | Boehringer Ingelheim International GmbH (DE) | 2006-01-18 | — | — | EP | disclosed |
| US-20040248779-A1 | Process for the preparation of macrocyclic compounds | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2004-12-09 | — | — | US | disclosed |
| WO-2004089974-A1 | PROCESS FOR THE PREPARATION OF MACROCYCLIC COMPOUNDS BY RUTHENIUM COMPLEX CATALYSED METATHESIS REACTION | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2004-10-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160075728-A1 | Chiral Imidazolium Salts for Asymmetric Catalysis | NDC1, NUDC, NIT2 | ALDH1A1 2659/4885MAPT 3842/4885NPSR1 3425/4885 |
| US-20040248779-A1 | Process for the preparation of macrocyclic compounds | CCND2, CYP1B1, PRMT1 | ALDH1A1 1680/4885MAPT 3723/4885NPSR1 1252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.